Healthcare provider profile · identity verified

Wilfredo Velez, MD

Internal Medicine · STATEN ISLAND, NY · NPI 1306807227

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	893	241
Amlodipine Besylate	Amlodipine Besylate	700	192
Losartan Potassium	Losartan Potassium	569	156
Levothyroxine Sodium	Levothyroxine Sodium	454	114
Simvastatin	Simvastatin	379	101
Hydrochlorothiazide	Hydrochlorothiazide	369	107
Metformin Hcl	Metformin Hcl	317	88
Metoprolol Succinate	Metoprolol Succinate	308	90
Omeprazole	Omeprazole	287	79
Alprazolam	Alprazolam	168	44
Rosuvastatin Calcium	Rosuvastatin Calcium	158	56
Gabapentin	Gabapentin	154	46
Lisinopril	Lisinopril	148	39
Metoprolol Tartrate	Metoprolol Tartrate	144	41
Tamsulosin Hcl	Tamsulosin Hcl	135	41
Albuterol Sulfate Hfa	Albuterol Sulfate	133	43
Eliquis	Apixaban	133	40
Furosemide	Furosemide	130	46
Enalapril Maleate	Enalapril Maleate	129	33
Lovastatin	Lovastatin	123	37
Pantoprazole Sodium	Pantoprazole Sodium	118	42
Sertraline Hcl	Sertraline Hcl	111	33
Alendronate Sodium	Alendronate Sodium	109	33
Fluticasone Propionate	Fluticasone Propionate	109	48
Montelukast Sodium	Montelukast Sodium	96	27
Clopidogrel	Clopidogrel Bisulfate	95	28
Atenolol	Atenolol	94	30
Famotidine	Famotidine	93	31
Finasteride	Finasteride	91	25
Glipizide Er	Glipizide	90	30
Ibuprofen	Ibuprofen	82	27
Synthroid	Levothyroxine Sodium	79	21
Ozempic	Semaglutide	71	15
Allopurinol	Allopurinol	68	20
Prednisone	Prednisone	66	53
Valsartan	Valsartan	63	17
Ezetimibe	Ezetimibe	59	20
Meloxicam	Meloxicam	59	25
Potassium Chloride	Potassium Chloride	57	16
Triamcinolone Acetonide	Triamcinolone Acetonide	57	24
Benazepril Hcl	Benazepril Hcl	53	13
Glipizide	Glipizide	53	16
Celecoxib	Celecoxib	52	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	50	43
Doxazosin Mesylate	Doxazosin Mesylate	48	13
Carvedilol	Carvedilol	47	15
Pregabalin	Pregabalin	47	suppressed
Donepezil Hcl	Donepezil Hcl	46	12
Azelastine Hcl	Azelastine Hcl	45	12
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Azithromycin	Azithromycin	44	40
Irbesartan	Irbesartan	44	12
Naproxen	Naproxen	44	12
Glimepiride	Glimepiride	43	13
Pravastatin Sodium	Pravastatin Sodium	43	13
Paroxetine Hcl	Paroxetine Hcl	42	suppressed
Januvia	Sitagliptin Phosphate	40	12
Terazosin Hcl	Terazosin Hcl	39	suppressed
Clonazepam	Clonazepam	38	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	38	suppressed
Klor-Con M10	Potassium Chloride	38	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	32
Jardiance	Empagliflozin	37	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Xarelto	Rivaroxaban	36	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	33	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	20
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Nifedipine Er	Nifedipine	32	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	11
Warfarin Sodium	Warfarin Sodium	31	suppressed
Ketoconazole	Ketoconazole	29	13
Meclizine Hcl	Meclizine Hcl	29	14
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Gemfibrozil	Gemfibrozil	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Amoxicillin	Amoxicillin	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	21
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Lactulose	Lactulose	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Trazodone Hcl	Trazodone Hcl	20	suppressed
Ibandronate Sodium	Ibandronate Sodium	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Dutasteride	Dutasteride	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	14
Fenofibrate	Fenofibrate	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Cilostazol	Cilostazol	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Jantoven	Warfarin Sodium	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Repaglinide	Repaglinide	15	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Tiadylt Er	Diltiazem Hcl	14	suppressed
Calcitriol	Calcitriol	13	suppressed
Clobetasol Emollient	Clobetasol Propionate/Emoll	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Torsemide	Torsemide	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Baclofen	Baclofen	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Anastrozole	Anastrozole	11	suppressed
Digoxin	Digoxin	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error